Clinical trials sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase breakdown

Conditions studied

Recruiting trials led by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

• 7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer
  NCT06826924 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)
  NCT04704505 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
  NCT07281768 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cardiometabolic Screening Program
  NCT05386719 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
  NCT06782932 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• DK222 Study at Hopkins
  NCT07140315 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
  NCT06059118 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Exercise in Prostate Cancer
  NCT06165302 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
  NCT06536881 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
  NCT03861676 · Phase: Early Phase 1 · Ages: 18 Years to 100 Years · Sex: Male · 1 location
• Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
  NCT05995821 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
  NCT06411691 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• KRAS-Targeted Vaccine With Chemoimmunotherapy, Nivolumab and Ipilimumab for Patients With NSCLC
  NCT05254184 · Phase: Phase 1 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
  NCT05013216 · Phase: Phase 1 · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
  NCT06941857 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC
  NCT06245889 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 2 locations
• Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
  NCT06138067 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC
  NCT05950139 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Physician- and Patient-based Barriers to NGS Testing
  NCT07209176 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
  NCT06389097 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
  NCT04363164 · Phase: Phase 2 · Ages: 18 Years to 90 Years · Sex: Male · 6 locations
• Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
  NCT07142551 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• The COSMYC Trial (COmbined Suppression of MYC)
  NCT06922318 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
  NCT06616597 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins recruiting for?

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is the lead sponsor of 24 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.